Central nervous system expression of HIV-1 gp120 activates the hypothalamic-pituitary-adrenal axis: Evidence for involvement of NMDA receptors and nitric oxide synthase

Virology

Volumn 226, Issue 2, 1996, Pages 362-373

  Raber, Jacob ^a,b   Toggas, Stephanie M ^a   Lee, Sherina ^a   Bloom, Floyd E ^a   Epstein, Charles J ^b   Mucke, Lennart ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CORTICOSTERONE; CORTICOTROPIN; ENVELOPE PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE SYNTHASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TRANSGENIC MOUSE;

EID: 0030589548     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0664     Document Type: Article

References (57)

1. Auphan, M., DiDonato, J. A., Rosette, C., Helmberg, A., and Karin, M. (1995). Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of l-κB synthesis. Science 270, 286-290.
2. Carlsson, D. E., and Gann, D. S. (1994). Effects of vasopressin antiserum on the response of adrenocorticotropin and cortisol to hemorrhage. Endocrinology 114, 317-324.
3. Cooper, J., Bloom, F. E., and Roth, R. H. (1991). In "The Biochemical Basis of Neuropharmacology," pp. 28-29. Oxford Univ. Press, Oxford.
4. Costa, A., Yasin, S. A., Hucks, D., Forsling, M. L., Besser, G. M., and Grossman, A. (1992). Differential effects of neuroexcitatory amino acids on corticotropin-releasing hormone-41 and vasopressin release from rat hypothalamic explants. Endocrinology 131, 2595-2602.
5. Dawson, V. L., Dawson, T. M., Uhl, G. R., and Snyder, S. H. (1993). Human immunodeficiency virus type I coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc. Natl. Acad. Sci. USA 90, 3256-3259.
6. Dawson, T. M., and Dawson, V. L. (1994). Gp120 neurotoxicity in primary cortical cultures. Adv. Neuroimmunol. 4, 167-173.
7. Dawson, V. L., Kizushi, V. M., Huang, P. L., Snyder, S. H., and Dawson, T. M. (1996). Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J. Neurosci. 16, 2479-2487.
8. DeLeon, M., McRae, T., and Tsai, J. R. (1988). Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy. Lancet ii, 391-392.
9. Dhabhar, F. S., Miller, A. H., McEwen, B. S., and Spencer, R. L. (1995). Differential activation of adrenal steroid receptors in neural and immune tissues of Sprague Dawley, Fischer 344, and Lewis rats. J. Neuroimmunol. 56, 77-90.
10. Epstein, C. J., Avraham, K. B., Lovett, M., Smith, S., Elroy-Stein, O., Rotman, G., Bry, C., and Groner, Y. (1987). Transgenic mice with increased Cu/Zn-superoxide dismutase activity: Animal model of dosage effects in Down syndrome. Proc. Natl. Acad. Sci. USA 84, 8044-8048.
11. Farah, J. M. J., Tadimeti, S., Rao, S., Mick, S. J., Coyne, K. E., and Iyengar, S. (1991). N-Methyl-D-Aspartate treatment increases circulating adrenocorticotropin and luteinizing hormone in the rat. Endocrinology 128, 1875-1880.
12. Gay, V. L., and Plant, T. M. (1987). N-Methyl-D,L-aspartate elicits hypothalamic gonadotropin-releasing hormone release in preburtal male rhesus monkeys (Macaca mulatta). Endocrinology 120, 2289-2296.
13. Giuffre, K. A., Udelsman, R., Listwak, S., and Chrousos, P. (1988). Effects of immunoneutralization of corticotropin-releasing hormone, adrenocorticotropin and beta-endorphin in the surgically stressed rat. Endocrinology 122, 306-310.
14. Hashimoto, K., Suemaru, S., Takao, T., Sugawara, M., Makino, S., and Fensuka, O. (1988). Corticotropin-releasing hormone and pituitary-adrenocortical responses in chronically stressed rats. Reg. Pept. 23, 117-126.
15. Hauger, R. L., Millar, M. A., Lorang, M., Harwood, J. P., and Aguilera, G. (1988). Corticotropin-releasing factor receptors and pituitary adrenal response during immobilization stress. Endocrinology 123, 396-404.
16. Iyengar, S., Mick, S., Dilworth, V., Michel, J., Rao, T. S., Farah, J. M., and Wood, P. L. (1990). Sigma receptors modulate the hypothalamic-pituitary-adrenal (HPA) axis centrally: Evidence for a functional interaction with NMDA receptors, in vivo. Neuropharmacology 29, 299-303.
17. Jezova, D., Oliver, C., and Jurcovicova, J. (1991). Stimulation of adrenocorticotropin but not prolactin and catecholamine release by N-methyl-aspartic acid. Neuroendocrinology 54, 488-492.
18. Landfield, P. W. (1987). Modulation of brain aging correlates by long-term alterations of adrenal steroids and neurally-active peptides. Prog. Brain Res. 72, 279-300.
19. Lincoln, G. A., and Wu, F. C. W. (1991). Effects of N-methyl-D,L-aspartate on β-endorphin and prolactin secretion in rams exposed to long or short days. J. Endocrinol. 5, 483-490.
20. Lipton, S. A., Choi, Y. B., Pan, Z. H., Lei, S. Z., Chen, H. S., Sucher, N. J., Loscalco, J., Singel, D. J., and Stamler, J. S. (1993). A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364, 626-632.
21. Lipton, S. A. (1994). HIV-related neuronal injury. Mol. Neurobiol. 8, 181-196.
22. Maitra, R., McMillan, N., Desai, S., McSwiggen, J., Hovanessian, A., Sen, G., Williams, B., and Silverman, R. (1994). HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology 204, 823-827.
23. McKeating, J. A., Cordell, J., Dean, C. J., and Balfe, P. (1992). Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120. Virology 191, 732-742.
24. Meeker, R. B., Swanson, D. J., Greenwood, R. S., and Hayward, J. N. (1993). Quantitative mapping of glutamate presynaptic terminals in the supraoptic nucleus and surrounding hypothalamus. Brain Res. 600, 112-122.
25. Mollace, V., Colasanti, M., Rodino, P., Lauro, G. M., and Nistico, G. (1994). HIV coating gp120 glycoprotein-dependent prostaglandin E2 release by human cultured astrocytoma cells is regulated by nitric oxide formation. Biochem. Biophys. Res. Commun. 203, 87-92.
26. Oberfield, S. E., Kairam, R., Bakshi, S., Bamji, M., Bhushan, V., Mayes, D., and Levine, L. S. (1990). Steroid response to adrenocorticotropin stimulation in children with human immunodeficiency virus infection. J. Clin. Endocrinol. Metab. 70, 578-581.
27. Patchev, V. K., Karalis, K., and Chrousos, G. P. (1994). Effects of excitatory amino acid transmitters on hypothalamic corticotropin-releasing hormone (CRH) and arginine-vasopressin (AVP) release in vitro: Implications in pituitary-adrenal regulation. Brain Res. 633, 312-316.
28. Pietraforte, D., Tritarelli, E., Testa, U., and Minetti, M. (1994). gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J. Leukocyte Biol. 55, 175-182.
29. Pittaluga, A., and Raiteri, M. (1994). HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings. Eur. J. Neurosci. 6, 1743-1749.
30. Pou, S., Pou, W. S., Bredt, D. S., Snyder, S. H., and Rosen, G. M. (1992). Generation of superoxide by purified brain nitric oxide synthase. J. Biol. Chem. 267, 24173-24176.
31. Przedborski, S., Kostic, V., Jackson-Lewis, V., Naini, A. B., Simonetti, S., Fahn, S., Carlson, E., Epstein, C. J., and Cadet, J. L. (1992). Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12, 1658-1667.
32. Price, R. W., and Perry, S. W. (1994). "HIV, AIDS, and the Brain." Raven Press, New York.
33. Raber, J., Merlo Pich, E. M., Koob, G. F., and Bloom, F. E. (1994). IL-1β potentiates the acetylcholine-induced release of vasopressin from the hypothalamus in vitro, but not from the amygdala. Neuroendocrinology 59, 208-217.
34. Refaeli, Y., Levy, D. N., and Weiner, D. B. (1995). The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. Proc. Natl. Acad. Sci. USA 92, 3621-3625.
35. Reichlin, S. (1993). Neuroendocrine-immune interactions. N. Engl. J. Med. 329, 1246-1253.
36. Reyes, A., Luckhaus, J., and Ferin, M. (1990). Unexpected inhibitory action of N-methyl-D,L-aspartate on luteinizing hormone release in adult ovariectomized rhesus monkeys: A role for the hypothalamic-adrenal axis. Endocrinology 127, 724-729.
37. Rivier, C. (1995). Influence of immune signals on the hypothalamic-pituitary axis of the rodent. Frontiers Neuroendocrinol. 16, 151-182.
38. Sapolsky, R. M. (1992). "Stress, the Aging Brain, and the Mechanisms of Neuron Death." MIT Press, Cambridge, MA.
39. Scaccianoce, S., Muscolo, L. A. A., Gigliana, G., Navarra, D., Nicolai, R., and Angelucci, L. (1991). Evidence for a specific role of vasporessin in sustaining pituitary-adrenocortical stress response in the rat. Endocrinology 128, 3138-3143.
40. Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., and Baldwin, A. S., Jr. (1995). Role of transcriptional activation of I-KBaα in mediation of immunosuppression by glucocorticoids. Science 270, 283-286.
41. Segal, R. A., Pomeroy, S. L., and Stiles, C. D. (1995). Axonal growth and fasculation linked to differential expression of BDNF and NT3 receptors in developing cerebellar granule cells. J. Neurosci. 15, 4970-4981.
42. Skowsky, W., Rosembloom, A. A., and Fisher, D. A. (1974). Radioimmunoassay of arginine vasopressin in serum: Development and application. J. Cell. Endocrinol. Metab. 38, 278-287.
43. Slotnick, B. M., and Leonard, C. M. (1975). "A Stereotaxic Atlas of the Albino Mouse Forebrain." U.S. Dept. Health, Education and Welfare, Rockville, MD.
44. Smith, M. A., Makino, S., Kvetnansky, R., and Post, R. M. (1995). Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci. 15, 1768-1777.
45. Starkman, M. N., Gebarski, S. S., Berent, S., and Schteingart, D. E. (1992). Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol. Psychiatry 32, 756-765.
46. Sternberg, E. M., Hill, J. M., Chrousos, G. P., Kamilaris, T., Listwak, S. J., Gold, P. W., and Wilder, R. L. (1989). Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Natl. Acad. Sci. USA 86, 2374-2378.
47. Toggas, S. M., Masliah, E., Rockenstein, E. M., Rall, G. F., Abraham, C. R., and Mucke, L. (1994). Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367, 188-193.
48. Toggas, S. M., Masliah, E., and Mucke, L. (1996a). Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res. 706, 303-307.
49. Toggas, S. M., and Mucke, L. (1996b). Transgenic animal models to assess the pathogenic potential of viral products in HIV-1 associated CNS disease. In "Neurological and Neuropsychiatric Manifestations of HIV-1 Infections" (H. E. Gendelman, S. Lipton, L. Epstein, and S. Swindells, Eds.), Chapmann and Hall, New York, in press.
50. Troy, C. M., Derossi, D., Prochiantz, A., Greene, L. A., and Shelanski, M. L. (1996). Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway. J. Neurosci. 16, 253-261.
51. Vago, T., Clerici, M., and Norbiato, G. (1994). Glucocorticoids and the immune system in AIDS. Bailliere Clin. Endocrinol. Metab. 8, 789-802.
52. van den Pol, A. N., Wuarin, J., and Dudek, F. E. (1990). Glutamate, the dominant excitatory transmitter in neuroendocrine regulation. Science 250, 1276-1278.
53. Weitzman, R., Glatz, T. H., and Fisher, D. A. (1978). The effect of hemorrhage and hypertonic saline upon plasma oxytocin and arginine vasopressin in conscious dogs. Endocrinology 103, 2154.
54. Wilckens, T. (1995). Glucocorticoids and immune function: Physiological relevance and pathogenic potential of hormonal dysfunction. Trends Pharmacol. Sci. 16, 193-197.
55. Wyss-Coray, T., Feng, L., Masliah, E., Ruppe, M. D., Lee, H. S., Toggas, S. M., and Flockenstein, E. M. (1995). Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β-1. Am. J. Pathol. 147, 53-67.
56. Wyss-Coray, T., Masliah, E., Toggas, S. M., Rockenstein, E. M., Brooker, M. J., Suk Lee, H., and Mucke, L. (1996). Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis. J. Clin. Invest. 97, 789-790.
57. Xia, Y., Dawson, V. L., Dawson, T. M., Snyder, S. H., and Zweier, J. L. (1996). Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc. Natl. Acad. Sci. USA 95, 6770-6774.